TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.
Roszik J, Markovits E, Dobosz P, Layani A, Slabodnik-Kaner K, Baruch EN, Ben-Betzalel G, Grimm E, Berger R, Sidi Y, Schachter J, Shapira-Frommer R, Avni D, Markel G, Leibowitz-Amit R.
Roszik J, et al. Among authors: avni d.
Cancer Immunol Immunother. 2019 Sep;68(9):1493-1500. doi: 10.1007/s00262-019-02382-0. Epub 2019 Sep 9.
Cancer Immunol Immunother. 2019.
PMID: 31501955
Free PMC article.